Rodriguez et al. first succeeded in inducing myxoid liposarcoma using BMSCs expressing the FUS-CHOP fusion protein and transformation with five oncogenic hits: TP53 deficiency, RB deficiency, hTERT overexpression, C-MYC stabilization, and HRASv12 overexpression [19]. Here, TP53 is linked to myxoid liposarcoma.